Pre-clinical study results demonstrated that BONESUPPORT’s CERAMENT™, loaded with rhBMP-2 + zoledronic acid in very low doses, was able to quantitatively/qualitatively generate a high amount of mineralized bone volume.
K2M received FDA 510(k) clearances to market CASCADIA™ Cervical and CASCADIA AN Lordotic Oblique Interbody systems, featuring Lamellar 3D-printed Titanium Technology™.
CollPlant received governmental authorization in Israel for funding of various 2016 development projects, including support of products to treat torn and inflamed tendons/ligaments.
MX Orthopedics was awarded a state-backed US $0.75MM Accelerator Loan. Funds will support commercialization of dynaMX™ superelastic orthopaedic fracture fixation implants.
Tyber Medical’s interbody spinal device line has been accepted into the Australian Registry of Therapeutic Goods. Private label partners are slated to launch products in 3Q16.Â